Opportunity overview
A project to replace the current contract has been concluded however due to the time that it takes to conduct a procurement exercise and the subsequent implementation period, delays have been encountered and have meant that a short extension is required to the current contract to ensure continuity of testing. This extension will be for a 6 month period from 01 November 2025.
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
Roche Diagnostics
Matched by normalised name
- Contract value
- £4.3m
- Awarded
- Not supplied
- Contract signed
- 3 Aug 2015
- Award ID
- 055505-2025-NP5023/14-1
- Status
- active
- Location
- Burgess Hill, UK, RH15 9RY, United Kingdom
Classification
- CPV50421000 — Repair and maintenance services of medical equipment
Lots
- The current managed service comprises the supply of a fully integrated microbiology managed service system for NAT (Nucleic Acid Testing). This includes equipment, maintenance, consumables, spare parts, upgrades, training, clinical education material, remote diagnostics, reporting and supports all to deliver a final result to the Authority’s information management system. Mandatory assays include the ability to detect HCV RNA (and HIV RNA for SNBTS) in plasma/serum samples from blood donors and also HCV RNA, HIV RNA and HBV DNA in plasma/ serum samples from tissue and stem cell donors.Value not stated